Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but ...

Robert F. Kennedy Jr. has vowed to combat "the chronic disease epidemic in this country" in the Trump administration, with ...

The FDA argues that, although Ubrelvy offers a significant therapeutic benefit to migraine sufferers, the advertising gives a ...

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

While the Supreme Court's ruling was directed at the advertising restrictions in section 503A of the Federal Food, Drug, and Cosmetic Act, it had the effect of invalidating the entire section ...

President Trump spent much of his first term skirmishing with the press. In his second term, it could become all-out war.

As 2024 ushers in political change, one of the most contentious issues bubbling beneath the surface is public health — notably, the role of addictive substances ...

The reelection of former President Donald Trump, coupled with Republicans gaining the Senate majority and poised to gain the House majority, ...

To date, Lilly's total revenue since the drug's launch, without advertising, is $3.2 billion. "We launched this drug almost a year ago and have done no advertising. So I think it is time to ...

Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the ...

The FDA swiftly reacted to the Western States Supreme Court decision. Less than 3 weeks after the decision, the agency issued a notice in the Federal Register seeking public comments on issues ...